van der Heijde, D., Deodhar, A., Fleischmann, R., Mease, P. J., Rudwaleit, M., Nurminen, T., & Davies, O. (2017). Early Disease Activity or Clinical Response as Predictors of Long‐Term Outcomes With Certolizumab Pegol in Axial Spondyloarthritis or Psoriatic Arthritis. Arthritis Care Res (Hoboken).
Citação norma Chicagovan der Heijde, D., A. Deodhar, R. Fleischmann, P. J. Mease, M. Rudwaleit, T. Nurminen, and O. Davies. "Early Disease Activity or Clinical Response As Predictors of Long‐Term Outcomes With Certolizumab Pegol in Axial Spondyloarthritis or Psoriatic Arthritis." Arthritis Care Res (Hoboken) 2017.
MLA引文van der Heijde, D., et al. "Early Disease Activity or Clinical Response As Predictors of Long‐Term Outcomes With Certolizumab Pegol in Axial Spondyloarthritis or Psoriatic Arthritis." Arthritis Care Res (Hoboken) 2017.